Polyamines and Their Metabolites as Diagnostic Markers of Human Diseases

  • Park, Myung Hee ;
  • Igarashi, Kazuei
  • Received : 2012.12.10
  • Accepted : 2013.01.04
  • Published : 2013.01.31


Polyamines, putrescine, spermidine and spermine, are ubiquitous in living cells and are essential for eukaryotic cell growth. These polycations interact with negatively charged molecules such as DNA, RNA, acidic proteins and phospholipids and modulate various cellular functions including macromolecular synthesis. Dysregulation of the polyamine pathway leads to pathological conditions including cancer, inflammation, stroke, renal failure and diabetes. Increase in polyamines and polyamine synthesis enzymes is often associated with tumor growth, and urinary and plasma contents of polyamines and their metabolites have been investigated as diagnostic markers for cancers. Of these, diacetylated derivatives of spermidine and spermine are elevated in the urine of cancer patients and present potential markers for early detection. Enhanced catabolism of cellular polyamines by polyamine oxidases (PAO), spermine oxidase (SMO) or acetylpolyamine oxidase (AcPAO), increases cellular oxidative stress and generates hydrogen peroxide and a reactive toxic metabolite, acrolein, which covalently incorporates into lysine residues of cellular proteins. Levels of protein-conjuagated acrolein (PC-Acro) and polyamine oxidizing enzymes were increased in the locus of brain infarction and in plasma in a mouse model of stroke and also in the plasma of stroke patients. When the combined measurements of PC-Acro, interleukin 6 (IL-6), and C-reactive protein (CRP) were evaluated, even silent brain infarction (SBI) was detected with high sensitivity and specificity. Considering that there are no reliable biochemical markers for early stage of stroke, PC-Acro and PAOs present promising markers. Thus the polyamine metabolites in plasma or urine provide useful tools in early diagnosis of cancer and stroke.


Polyamine metabolites;Acrolein;Diacetylspemine;Diagnostic marker;Cancer;Stroke


  1. Agostinelli, E., Tempera, G., Viceconte, N., Saccoccio, S., Battaglia, V., Grancara, S., Toninello, A. and Stevanato, R. (2010) Potential anticancer application of polyamine oxidation products formed by amine oxidase: a new therapeutic approach. Amino Acids 38, 353-368.
  2. Auvinen, M., Paasinen, A., Andersson, L. C. and Holtta, E. (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature 360, 355-358.
  3. Babbar, N., Murray-Stewart, T. and Casero, R. A. Jr. (2007) Inflammation and polyamine catabolism: the good, the bad and the ugly. Biochem. Soc. Trans. 35, 300-304.
  4. Bachrach, U. (2005) Naturally occurring polyamines: interaction with macromolecules. Curr. Protein Pept. Sci. 6, 559-566.
  5. Becerra-Solano, L. E., Butler, J., Castaneda-Cisneros, G., McCloskey, D. E., Wang, X., Pegg, A. E., Schwartz, C. E., Sanchez-Corona, J. and Garcia-Ortiz, J. E. (2009) A missense mutation, p.V132G, in the X-linked spermine synthase gene (SMS) causes Snyder-Robinson syndrome. Am. J. Med. Genet. A 149A, 328-335.
  6. Bokura, H., Kobayashi, S., Yamaguchi, S., Iijima, K., Nagai, A., Toyoda, G., Oguro, H. and Takahashi, K. (2006) Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J. Stroke Cerebrovasc. Dis. 15, 57-63.
  7. Byers, T. L., Lakanen, J. R., Coward, J. K. and Pegg, A. E. (1994) The role of hypusine depletion in cytostasis induced by S-adenosyl-L-methionine decarboxylase inhibition: new evidence provided by 1-methylspermidine and 1,12-dimethylspermine. Biochem. J. 303, 363-368.
  8. Casero, R. A. Jr. and Marton, L. J. (2007) Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug Discov. 6, 373-390.
  9. Cerrada-Gimenez, M., Pietila, M., Loimas, S., Pirinen, E., Hyvonen, M. T., Keinanen, T. A., Janne, J. and Alhonen, L. (2011) Continuous oxidative stress due to activation of polyamine catabolism accelerates aging and protects against hepatotoxic insults. Transgenic Res. 20, 387-396.
  10. Clifford, A., Morgan, D., Yuspa, S. H., Soler, A. P. and Gilmour, S. (1995) Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res. 55, 1680-1686.
  11. Coffino, P. (2001) Regulation of cellular polyamines by antizyme. Nat. Rev. Mol. Cell Biol. 2, 188-194.
  12. Dingledine, R., Borges, K., Bowie, D. and Traynelis, S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
  13. Fleidervish, I. A., Libman, L., Katz, E. and Gutnick, M. J. (2008) Endogenous polyamines regulate cortical neuronal excitability by blocking voltage-gated Na+ channels. Proc. Natl. Acad. Sci. USA 105, 18994-18999.
  14. Fujita, K., Murakami, Y. and Hayashi, S. (1982) A macromolecular inhibitor of the antizyme to ornithine decarboxylase. Biochem. J. 204, 647-652.
  15. Gerner, E. W. and Meyskens, F. L. Jr. (2004). Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 4, 781-792.
  16. Gerner, E. W. and Meyskens, F. L. Jr. (2009) Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin. Cancer Res. 15, 758-761.
  17. Gimelli, G., Giglio, S., Zuffardi, O., Alhonen, L., Suppola, S., Cusano, R., Lo Nigro, C., Gatti, R., Ravazzolo, R. and Seri, M. (2002) Gene dosage of the spermidine/spermine N(1)-acetyltransferase ( SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD). Hum. Genet. 111, 235-241.
  18. Giorgio, M., Trinei, M., Migliaccio, E. and Pelicci, P. G. (2007) Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat. Rev. Mol. Cell Biol. 8, 722-728.
  19. Gomez, M. and Hellstrand, P. (1995) Effects of polyamines on voltage-activated calcium channels in guinea-pig intestinal smooth muscle. Pflugers Arch. 430, 501-507.
  20. Herr, H. W., Kleinert, E. L., Conti, P. S., Burchenal, J. H. and Whitmore, W.F., Jr. (1984) Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. Cancer Res. 44, 4382-4385.
  21. Higgins, M. L., Tillman, M. C., Rupp, J. P. and Leach, F. R. (1969) The effect of polyamines on cell culture cells. J. Cell. Physiol. 74, 149-154.
  22. Hiramatsu, K., Takahashi, K., Yamaguchi, T., Matsumoto, H., Miyamoto, H., Tanaka, S., Tanaka, C., Tamamori, Y., Imajo, M., Kawaguchi, M. et al. (2005) N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers. Clin. Cancer Res. 11, 2986-2990.
  23. Hobbs, C. A., Paul, B. A. and Gilmour, S. K. (2002) Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors. Cancer Res. 62, 67-74.
  24. Hoshi, T., Kitagawa, K., Yamagami, H., Furukado, S., Hougaku, H. and Hori, M. (2005) Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36, 768-772.
  25. Hyvonen, M. T., Keinanen, T. A., Cerrada-Gimenez, M., Sinervirta, R., Grigorenko, N., Khomutov, A. R., Vepsalainen, J., Alhonen, L. and Janne, J. (2007) Role of hypusinated eukaryotic translation initiation factor 5A in polyamine depletion-induced cytostasis. J. Biol. Chem. 282, 34700-34706.
  26. Igarashi, K. and Kashiwagi, K. (2000) Polyamines: mysterious modulators of cellular functions. Biochem. Biophys. Res. Commun. 271, 559-564.
  27. Igarashi, K. and Kashiwagi, K. (2010) Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 42, 39-51.
  28. Igarashi, K. and Kashiwagi, K. (2011a) Use of polyamine metabolites as markers for stroke and renal failure. Methods Mol. Biol. 720, 395-408.
  29. Igarashi, K. and Kashiwagi, K. (2011b) Protein-conjugated acrolein as a biochemical marker of brain infarction. Mol. Nutr. Food Res. 55, 1332-1341.
  30. Igarashi, K., Ueda, S., Yoshida, K. and Kashiwagi, K. (2006) Polyamines in renal failure. Amino Acids 31, 477-483.
  31. Inoue, K., Matsumoto, M., Shono, T., Toyokawa, S. and Moriki, A. (2007) Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts. J. Stroke Cerebrovasc. Dis. 16, 14-20.
  32. Ivanov, I. P., Gesteland, R. F., Matsufuji, S. and Atkins, J. F. (1998) Programmed frameshifting in the synthesis of mammalian antizyme is +1 in mammals, predominantly +1 in fission yeast, but -2 in budding yeast. RNA 4, 1230-1238.
  33. Janne, J., Alhonen, L., Pietila, M. and Keinanen, T. A. (2004) Genetic approaches to the cellular functions of polyamines in mammals. Eur. J. Biochem. 271, 877-894.
  34. Jin, L., Miyazaki, M., Mizuno, S., Takigawa, M., Hirose, T., Nishimura, K., Toida, T., Williams, K., Kashiwagi, K. and Igarashi, K. (2008) The pore region of N-methyl-D-aspartate receptors differentially influences stimulation and block by spermine. J. Pharmacol. Exp. Ther. 327, 68-77.
  35. Joe, Y. A., Wolff, E. C. and Park, M. H. (1995) Cloning and expression of human deoxyhypusine synthase cDNA. Structure-function studies with the recombinant enzyme and mutant proteins. J. Biol. Chem. 270, 22386-22392.
  36. Kaasinen, S. K., Oksman, M., Alhonen, L., Tanila, H. and Janne, J. (2004) Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment. Pharmacol. Biochem. Behav. 78, 35-45.
  37. Kawakita, M. and Hiramatsu, K. (2006) Diacetylated derivatives of spermine and spermidine as novel promising tumor markers. J. Biochem. 139, 315-322.
  38. Kramer, D. L., Diegelman, P., Jell, J., Vujcic, S., Merali, S. and Porter, C. W. (2008) Polyamine acetylation modulates polyamine metabolic flux, a prelude to broader metabolic consequences. J. Biol. Chem. 283, 4241-4251.
  39. Kramer, D. L., Paul, B. and Porter, C. W. (1985) Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice. Cancer Res. 45, 2512-2515.
  40. Landau, G., Ran, A., Bercovich, Z., Feldmesser, E., Horn-Saban, S., Korkotian, E., Jacob-Hirsh, J., Rechavi, G., Ron, D. and Kahana, C. (2012) Expression profiling and biochemical analysis suggest stress response as a potential mechanism inhibiting proliferation of polyamine-depleted cells. J. Biol. Chem. 287, 35825-35837.
  41. Lawson, K., Larentowicz, L., Laury-Kleintop, L. and Gilmour, S. K. (2005) B23 is a downstream target of polyamine-modulated CK2. Mol. Cell. Biochem. 274, 103-114.
  42. Linden, A. (2006) Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J. Eval. Clin. Pract. 12, 132-139.
  43. Lopez, O. L., Jagust, W. J., Dulberg, C., Becker, J. T., DeKosky, S. T., Fitzpatrick, A., Breitner, J., Lyketsos, C., Jones, B., Kawas, C. et al. (2003) Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch. Neurol. 60, 1394-1399.
  44. Mamont, P. S., Duchesne, M. C., Grove, J. and Bey, P. (1978) Anti-proliferative properties of DL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem. Biophys. Res. Commun. 81, 58-66.
  45. Mandal, S., Mandal, A., Johansson, H. E., Orjalo, A. V. and Park, M. H. (2013) Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells. Proc. Natl. Acad. Sci. USA in press published ahead of print January 23, 2013, doi:10.1073/pnas.1219002110
  46. Matthews, H. R. (1993) Polyamines, chromatin structure and transcription. Bioessays 15, 561-566.
  47. Minois, N., Carmona-Gutierrez, D. and Madeo, F. (2011) Polyamines in aging and disease. Aging (Albany NY) 3, 716-732.
  48. Mize, G. J., Ruan, H., Low, J. J. and Morris, D. R. (1998) The inhibitory upstream open reading frame from mammalian S-adenosylmethionine decarboxylase mRNA has a strict sequence specificity in critical positions. J. Biol. Chem. 273, 32500-32505.
  49. Nakaike, S., Kashiwagi, K., Terao, K., Iio, K. and Igarashi, K. (1988) Combined use of alpha-difluoromethylornithine and an inhibitor of S-adenosylmethionine decarboxylase in mice bearing P388 leukemia or Lewis lung carcinoma. Jpn. J. Cancer Res. 79, 501-508.
  50. Nishimura, K., Lee, S. B., Park, J. H. and Park, M. H. (2012) Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development. Amino Acids 42, 703-710.
  51. Nishimura, K., Murozumi, K., Shirahata, A., Park, M. H., Kashiwagi, K. and Igarashi, K. (2005) Independent roles of eIF5A and polyamines in cell proliferation. Biochem. J. 385, 779-785.
  52. Nishimura, K., Nakatsu, F., Kashiwagi, K., Ohno, H., Saito, T. and Igarashi, K. (2002) Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development. Genes Cells 7, 41-47.
  53. Nishimura, K., Shiina, R., Kashiwagi, K. and Igarashi, K. (2006) Decrease in polyamines with aging and their ingestion from food and drink. J. Biochem. 139, 81-90.
  54. Ogasawara, T., Ito, K. and Igarashi, K. (1989) Effect of polyamines on globin synthesis in a rabbit reticulocyte polyamine-free protein synthetic system. J. Biochem. 105, 164-167.
  55. Oredsson, S. M., Alm, K., Dahlberg, E., Holst, C. M., Johansson, V. M., Myhre, L. and Soderstjerna, E. (2007) Inhibition of cell proliferation and induction of apoptosis by N1,N11-diethylnorspermine-induced polyamine pool reduction. Biochem. Soc. Trans. 35, 405-409.
  56. Oredsson, S. M., Anehus, S. and Heby, O. (1984) Reversal of the growth inhibitory effect of alpha-difluoromethylornithine by putrescine but not by other divalent cations. Mol. Cell. Biochem. 64, 163-172.
  57. Park, J. H., Aravind, L., Wolff, E. C., Kaevel, J., Kim, Y. S. and Park, M. H. (2006) Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metallo-enzyme. Proc. Natl. Acad. Sci. USA 103, 51-56.
  58. Park, M. H. (2006) The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). J. Biochem. 139, 161-169.
  59. Park, M. H., Nishimura, K., Zanelli, C. F. and Valentini, S. R. (2010) Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 38, 491-500.
  60. Patel, A. R. and Wang, J. Y. (1997) Polyamines modulate transcription but not posttranscription of c-myc and c-jun in IEC-6 cells. Am. J. Physiol. 273, C1020-1029.
  61. Pegg, A. E. (2008) Spermidine/spermine-N1-acetyltransferase: a key metabolic regulator. Am. J. Physiol. Endocrinol. Metab. 294, E995-1010.
  62. Pegg, A. E. (2009) Mammalian polyamine metabolism and function. IUBMB Life 61, 880-894.
  63. Pegg, A. E. and Casero, R. A. Jr. (2011) Current status of the polyamine research field. Methods Mol. Biol. 720, 3-35.
  64. Pendeville, H., Carpino, N., Marine, J. C., Takahashi, Y., Muller, M., Martial, J. A. and Cleveland, J. L. (2001) The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol. Cell. Biol. 21, 6549-6558.
  65. Quigley, G. J., Teeter, M. M. and Rich, A. (1978) Structural analysis of spermine and magnesium ion binding to yeast phenylalanine transfer RNA. Proc. Natl. Acad. Sci. USA 75, 64-68.
  66. Russell, D. and Snyder, S. H. (1968) Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc. Natl. Acad. Sci. USA 60, 1420-1427.
  67. Russell, D. H., Levy, C. C., Schimpff, S. C. and Hawk, I. A. (1971) Urinary polyamines in cancer patients. Cancer Res. 31, 1555-1558.
  68. Saiki, R., Nishimura, K., Ishii, I., Omura, T., Okuyama, S., Kashiwagi, K. and Igarashi, K. (2009) Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 40, 3356-3361.
  69. Saiki, R., Park, H., Ishii, I., Yoshida, M., Nishimura, K., Toida, T., Tatsukawa, H., Kojima, S., Ikeguchi, Y., Pegg, A. E. et al. (2011) Brain infarction correlates more closely with acrolein than with reactive oxygen species. Biochem. Biophys. Res. Commun. 404, 1044-1049.
  70. Seppanen, P., Alhonen-Hongisto, L. and Janne, J. (1983) Combined use of 2-difluoro-methylornithine and methylglyoxal bis (guanylhydrazone) in normal and leukemia-bearing mice. Cancer Lett. 18, 1-10.
  71. Sequeira, A., Gwadry, F. G., Ffrench-Mullen, J. M., Canetti, L., Gingras, Y., Casero, R. A. Jr., Rouleau, G., Benkelfat, C. and Turecki, G. (2006) Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch. Gen. Psychiatry 63, 35-48.
  72. Sharmin, S., Sakata, K., Kashiwagi, K., Ueda, S., Iwasaki, S., Shirahata, A. and Igarashi, K. (2001) Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem. Biophys. Res. Commun. 282, 228-235.
  73. Shin, J., Shen, F. and Huguenard, J. R. (2005) Polyamines modulate AMPA receptor-dependent synaptic responses in immature layer v pyramidal neurons. J. Neurophysiol. 93, 2634-2643.
  74. Soda, K., Dobashi, Y., Kano, Y., Tsujinaka, S. and Konishi, F. (2009) Polyamine-rich food decreases age-associated pathology and mortality in aged mice. Exp. Gerontol. 44, 727-732.
  75. Stanfield, P. R. and Sutcliffe, M. J. (2003) Spermine is fit to block inward rectifier (Kir) channels. J. Gen. Physiol. 122, 481-484.
  76. Stevens, J. F. and Maier, C. S. (2008) Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52, 7-25.
  77. Tabor, C. W. and Tabor, H. (1984) Polyamines. Ann. Rev. Biochem. 53, 749-790.
  78. Thomas, T. and Thomas, T. J. (2001) Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 58, 244-258.
  79. Tomitori, H., Usui, T., Saeki, N., Ueda, S., Kase, H., Nishimura, K., Kashiwagi, K. and Igarashi, K. (2005) Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 36, 2609-2613.
  80. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N. and Niki, E. (1998) Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273, 16058-16066.
  81. Vermeer, S. E., Longstreth, W. T. Jr. and Koudstaal, P. J. (2007) Silent brain infarcts: a systematic review. Lancet Neurol. 6, 611-619.
  82. Wallace, H. M., Duthie, J., Evans, D. M., Lamond, S., Nicoll, K. M. and Heys, S. D. (2000) Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin. Cancer Res. 6, 3657-3661.
  83. Wang, X., Levic, S., Gratton, M. A., Doyle, K. J., Yamoah, E. N. and Pegg, A. E. (2009) Spermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine. J. Biol. Chem. 284, 930-937.
  84. Wang, Y., Xiao, L., Thiagalingam, A., Nelkin, B. D. and Casero, R. A. Jr. (1998) The identification of a cis-element and a trans-acting factor involved in the response to polyamines and polyamine analogues in the regulation of the human spermidine/spermine N1-acetyltransferase gene transcription. J. Biol. Chem. 273, 34623-34630.
  85. Watanabe, S., Kusama-Eguchi, K., Kobayashi, H. and Igarashi, K. (1991) Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J. Biol. Chem. 266, 20803-20809.
  86. Williams-Ashman, H. G. and Schenone, A. (1972) Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases. Biochem. Biophys. Res. Commun. 46, 288-295.
  87. Yoshida, M., Higashi, K., Kobayashi, E., Saeki, N., Wakui, K., Kusaka, T., Takizawa, H., Kashiwado, K., Suzuki, N., Fukuda, K. et al. (2010) Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis 211, 475-479.
  88. Yoshida, M., Tomitori, H., Machi, Y., Hagihara, M., Higashi, K., Goda, H., Ohya, T., Niitsu, M., Kashiwagi, K. and Igarashi, K. (2009) Acrolein toxicity: Comparison with reactive oxygen species. Biochem. Biophys. Res. Commun. 378, 313-318.

Cited by

  1. Self-Immolative Polycations as Gene Delivery Vectors and Prodrugs Targeting Polyamine Metabolism in Cancer vol.12, pp.2, 2015,
  2. Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine vol.441, 2015,
  3. Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis С virus proteins in Huh7.5 human hepatocarcinoma cells vol.51, pp.3, 2017,
  4. Astrocyte-Dependent Vulnerability to Excitotoxicity in Spermine Oxidase-Overexpressing Mouse vol.18, pp.1, 2016,
  5. Metabolic Consequences of Chronic Alcohol Abuse in Non-Smokers: A Pilot Study vol.10, pp.6, 2015,
  6. Molecularly imprinted fluorescent chemosensor synthesized using quinoline-modified-β-cyclodextrin as monomer for spermidine recognition vol.5, pp.68, 2015,
  7. Low-level maternal exposure to nicotine associates with significant metabolic perturbations in second-trimester amniotic fluid vol.107, 2017,
  8. Synthesis, structure and antiproliferative activity of chiral polyamines based on a 2-azanorbornane skeleton vol.27, pp.16, 2016,
  9. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease vol.12, 2017,
  10. Functions of Polyamines in Mammals vol.291, pp.29, 2016,
  11. Extracellular polyamines-induced proliferation and migration of cancer cells by ODC, SSAT, and Akt1-mediated pathway vol.28, pp.4, 2017,
  12. In vitro Metabolomic Approaches to Investigating the Potential Biological Effects of Phenolic Compounds: An Update vol.15, pp.4, 2017,
  13. Evaluation of dementia by acrolein, amyloid-β and creatinine vol.450, 2015,
  14. Decrease in acrolein toxicity based on the decline of polyamine oxidases vol.79, 2016,
  15. Functional Role of Milk Fat Globule-Epidermal Growth Factor VIII in Macrophage-Mediated Inflammatory Responses and Inflammatory/Autoimmune Diseases vol.2016, 2016,
  16. A useful procedure for detection of polyamines in biological samples as a potential diagnostic tool in cancer diagnosis vol.37, pp.1, 2017,
  17. Untargeted and targeted methodologies in the study of tea (Camellia sinensis L.) vol.63, 2014,
  18. Putrescine oxidase/peroxidase-co-immobilized and mediator-less mesoporous microelectrode for diffusion-controlled steady-state amperometric detection of putrescine 2017,
  19. Functional Roles of Syk in Macrophage-Mediated Inflammatory Responses vol.2014, 2014,
  20. Urinary Polyamines as Biomarkers for Ovarian Cancer vol.27, pp.7, 2017,
  21. AP-1-Targeted Inhibition of Macrophage Function and Lipopolysaccharide/D-Galactosamine-Induced Hepatitis by Phyllanthus acidus Methanolic Extract vol.43, pp.06, 2015,
  22. Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State vol.50, pp.4, 2016,
  23. Altering the Mitochondrial Fatty Acid Synthesis (mtFASII) Pathway Modulates Cellular Metabolic States and Bioactive Lipid Profiles as Revealed by Metabolomic Profiling vol.11, pp.3, 2016,
  24. Determination of putrescine, cadaverine, spermidine and spermine in different chemical matrices by high performance liquid chromatography–electrospray ionization–ion trap tandem mass spectrometry (HPLC–ESI–ITMS/MS) vol.1002, 2015,
  25. HIV-Tat Induces the Nrf2/ARE Pathway through NMDA Receptor-Elicited Spermine Oxidase Activation in Human Neuroblastoma Cells vol.11, pp.2, 2016,
  26. Drug Resistance in Mycobacterium tuberculosis vol.147, pp.4, 2015,
  27. The metabolomic detection of lung cancer biomarkers in sputum vol.94, 2016,
  28. Atractylodes macrocephala Koidz stimulates intestinal epithelial cell migration through a polyamine dependent mechanism vol.159, 2015,
  29. Untargeted Metabolomics To Ascertain Antibiotic Modes of Action vol.60, pp.4, 2016,
  30. Skeletal Muscle Pathophysiology: The Emerging Role of Spermine Oxidase and Spermidine vol.6, pp.1, 2018,
  31. Spermidine in health and disease vol.359, pp.6374, 2018,
  32. Endogenous and food-derived polyamines: determination by electrochemical sensing vol.50, pp.9, 2018,
  33. Spectroscopic methods to analyze drug metabolites vol.41, pp.4, 2018,
  34. Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever vol.27, pp.6, 2018,
  35. The Involvement of Arginase and Nitric Oxide Synthase in Breast Cancer Development: Arginase and NO Synthase as Therapeutic Targets in Cancer vol.2018, pp.2314-6141, 2018,
  36. Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities—Metabiotics: Probiotics Effector Molecules vol.09, pp.04, 2018,
  37. Programmable RNA-based systems for sensing and diagnostic applications pp.1618-2650, 2019,